Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Randomized phase II study of pemetrexed and cisplatin as either induction or adjuvant chemotherapy in stage IB-II non-small cell lung cancer.

Trial Profile

Randomized phase II study of pemetrexed and cisplatin as either induction or adjuvant chemotherapy in stage IB-II non-small cell lung cancer.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 25 Oct 2015

At a glance

  • Drugs Cisplatin; Pemetrexed
  • Indications Non-small cell lung cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 26 Jul 2012 Actual end date (July 2008) added as reported by ClinicalTrials.gov.
    • 31 Aug 2009 Status changed from active, no longer recruiting to discontinued.
    • 01 Aug 2009 Results have been presented at the 13th World Conference on Lung Cancer.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top